Virginia Tech™home

Archived Seminar: Design and Optimization of CAR T cells and their Application to Glioblastoma

Pioneers in Biomedical Research Seminar presented by the Fralin Biomedical Research Institute at VTC

Archived Seminar: Design and Optimization of CAR T Cells and Their Application to Glioblastoma

Date: Sept. 18, 2020
Time: 11:00 a.m. - 12:00 p.m.

Abstract

Encouraging clinical experience with chimeric antigen receptor (CAR) T cells supports the notion that even immune privileged sites such as the brain may be amenable to CAR therapy. In the context of hematologic B-cell malignancies, CD19-CARs have been shown to accumulate in the cerebrospinal fluid (CSF) and reduce the incidence of metastatic disease in the central nervous system. However, brain tumors pose significant challenges for CAR T cell therapy, including heterogeneous antigen expression, immunosuppressive networks in the tumor microenvironment that limit CAR T cell function and persistence, and suboptimal T cell trafficking to the tumor site. This presentation will describe our clinical experience with CAR T cells for glioblastoma (GBM), one of the most common and aggressive primary malignant brain tumors, and our efforts to overcome therapeutic challenges.

Additional Details 

This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Cancer Research Group. The Fralin Biomedical Research Institute Pioneers in Biomedical Research Program offers the expertise of a range of scientists who are exploring frontiers in biomedical research. These seminars are open to Virginia Tech and Carilion Clinic faculty, students, and staff.

 

You May Also Be Interested In...

Christine Brown, Ph.D. to present at Fralin Biomedical Research Institute

Christine Brown, Ph.D. 

Professor in the Department of Hematology and Hematopoietic Cell Transplantation; Heritage Provider Network Professor in Immunotherapy; and Deputy Director of the T Cell Therapeutics Research Laboratory, at City of Hope